Characterisation of thymidine dimer excretion in mice following UV exposure, indicating potential for drug screening.
DNA damage in the form of thymidine dimers (T < > Ts) is formed in the skin in response to ultraviolet radiation (UVR). T < > Ts are excised from the skin and excreted into the urine at a quantifiable concentration. Recently, detection of T < > Ts were described in murine urine, but little is known about the excretion pattern or kinetics of T < > Ts in murine models following UVR. This study presents a characterisation of the urinary excretion of T < > Ts in hairless mice exposed to UVR. Using ultrahigh-performance liquid chromatography coupled to mass spectrometry, T < > T excretion showed a linear relationship with the UVR dose mice were exposed to, with an age-dependent decline in DNA repair capacity. Factors such as UVR exposure source and time for urine collection also impacted T < > T concentration. When applying the method to test three types of treatments for their effect on T < > T excretion, results showed an effect from sunscreen and immunosuppressants but not nicotinamide despite reports of protection. Overall, the findings demonstrate the potential of a new non-invasive method to screen drug candidates for how they affect repair of T < > Ts. Application of such a test system may advance the discovery of new treatment options to better protect against skin cancer.
No takes yet. Share an insight, caveat, or question.
Pihl et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: